Literature DB >> 33459041

Inferior vena cava-syndrome.

Peter Franz Klein-Weigel1, Saban Elitok2, Andreas Ruttloff1, Sabine Reinhold1, Jessica Nielitz1, Julia Steindl1, Philippe Lutfi1, Lars Rehmenklau-Bremer3, Birgit Hillner3, Heiko Fuchs4, Christian Wrase4, Thomas Herold3, Lukas Beyer4.   

Abstract

Inferior vena cava syndrome (IVCS) is caused by agenesis, compression, invasion, or thrombosis of the IVC, or may be associated with Budd-Chiari syndrome. Its incidence and prevalence are unknown. Benign IVCS is separated from malignant IVCS. Both cover a wide clinical spectrum reaching from asymptomatic to highly symptomatic cases correlated to the underlying cause, the acuity, the extent of the venous obstruction, and the recruitment and development of venous collateral circuits. Imaging is necessary to determine the underlying cause of IVCS and to guide clinical decisions. Interventional therapy has changed the therapeutic approach in symptomatic patients. This article provides an overview over IVCS and focuses on interventional therapeutic methods and results.

Entities:  

Keywords:  Budd-Chiari syndrome; Inferior vena cava syndrome; catheter-directed thrombolysis; inferior vena cava thrombosis; thrombaspiration; tumor compression; venous stenting

Mesh:

Year:  2021        PMID: 33459041     DOI: 10.1024/0301-1526/a000919

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  1 in total

1.  Malignant obstruction of the inferior vena cava: clinical experience with the self-expanding Sinus-XL stent system.

Authors:  Anne Marie Augustin; Leonie Johanna Lucius; Annette Thurner; Ralph Kickuth
Journal:  Abdom Radiol (NY)       Date:  2022-07-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.